Boston Scientific Corp (XTER:BSX)
€ 86.5 -0.5 (-0.57%) Market Cap: 126.52 Bil Enterprise Value: 134.81 Bil PE Ratio: 74.93 PB Ratio: 6.45 GF Score: 79/100

Boston Scientific Corp at Leerink Partners Global Healthcare Conference Transcript

Feb 28, 2019 / 04:30PM GMT
Danielle Joy Antalffy
SVB Leerink LLC, Research Division - MD of Medical Supplies & Devices and Senior Analyst

Okay. Let's get started. Good morning, everyone. My name's Danielle Antalffy. I am one of the medtech analysts here at SVB Leerink. And we are very lucky to have with us from Boston Scientific, Joe Fitzgerald. He is EVP and President of Rhythm Management; as well as Susie Lisa, Head of Investor Relations. And this is going to be fireside chat format, should we just launch right into Q&A? And if anyone has a question, feel free to raise your hand. And if you're lucky, maybe I'll call on you. No, I'm kidding.

Questions & Answers

Danielle Joy Antalffy
SVB Leerink LLC, Research Division - MD of Medical Supplies & Devices and Senior Analyst

Okay. So Joe, at your Analyst Day, you talked about Rhythm Management being a $14 billion market, growing at about 3%. Can you talk about any possible market adjacencies that could potentially grow this addressable market? And given your category leadership strategy, what's the right way to think

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot